Table 2 Characteristics of patients treated with amplitude-modulated electromagnetic fields
Characteristic | No | % |
|---|---|---|
Age, years | ||
Median | 61.0 | |
Range | 30–82 | |
Sex | ||
Male | 11 | 39.3 |
Female | 17 | 60.7 |
Performance status, ECOG | ||
0 | 1 | 3.6 |
1 | 21 | 75.0 |
2 | 6 | 21.4 |
Sites of primary disease | ||
Breast | 7 | 25.0 |
Ovary | 5 | 17.9 |
Pancreas | 3 | 10.7 |
Colon | 2 | 7.1 |
Prostate | 2 | 7.1 |
Glioblastoma multiforme | 1 | 3.6 |
Hepatocellular carcinoma | 1 | 3.6 |
Mesothelioma | 1 | 3.6 |
Neuroendocrine | 1 | 3.6 |
NSCLC | 1 | 3.6 |
Oligodendroglioma | 1 | 3.6 |
SCLC | 1 | 3.6 |
Sarcoma | 1 | 3.6 |
Thyroid | 1 | 3.6 |
Prior systemic therapy | ||
Yes | 22 | 78.6 |
No | 6 | 21.4 |